Composition containing angelica extract for promoting proliferation of stem cells derived from bone marrow

Abstract

The present invention relates to a composition for promoting proliferation of bone marrow derived stem cells using an angelicae gigantis radix extract, and more particularly, to a composition which administers a granulocyte colony-stimulating factor into an object, and administers the angelicae gigantis radix extract to the object to promote the proliferation of the bone marrow derived stem cells. The composition of the present invention solves side effects such as splenomegaly which were caused by a method of administering only the G-CSF for proliferation and differentiation of the stem cells, thereby significantly mitigating the side effects through co-administration of the angelicae gigantis radix extract, and further promoting the proliferation and the differentiation of the stem cells.

1 . A pharmaceutical composition for promoting proliferation of bone marrow derived stem cells, the composition comprising:
 a granulocyte colony-stimulating factor; and   an angelicae gigantis radix extract,   wherein the stem cells are CD34+ cells.   
     
     
         2 . The composition according to  claim 1 , wherein the stimulating factor and the angelicae gigantis radix extract are mixed in advance and made into a dosage form, or separately made into a dosage form. 
     
     
         3 . The composition according to  claim 1 , wherein the stimulating factor and the angelicae gigantis radix extract are administered parenterally, orally, locoregionally, or percutaneously. 
     
     
         4 . The composition according to  claim 1 , wherein a period of administering the angelicae gigantis radix extract begins within thirty minutes after administration of the stimulating factor.